The European brachytherapy market is anticipated to grow at a CAGR of 3.6% during the forecast period. According to the World Health Organization, cancer is the second most common cause of fatality and morbidity in Europe with around 3.7 million cases and 1.9 million fatalities each year. In Europe, tobacco consumption and excessive alcohol consumption cause about 40% of the total cancer burden. If the consequences of inappropriate diet, obesity, and insufficient physical activity are added, the percentage of cancers due to an unhealthy lifestyle rises to 60%.
Browse the full report description European Brachytherapy Market Size, Share & Trends Analysis Report by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer, Skin Cancer, Brain Cancer, and Others), and by Type (Low-Dose Rate (LDR) Brachytherapy and High-Dose Rate (HDR) Brachytherapy) Forecast Period, 2020-2026 at https://www.omrglobal.com/industry-reports/europe-brachytherapy-market
Although more than 40% of cancer mortalities can be prevented, cancer accounts for 20% of deaths in the European Region. This high prevalence of cancer in Europe will give significant growth to the brachytherapy industry.
Market Coverage
o By Indication
o By Type
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
Key Questions Addressed by the report
European Brachytherapy Market Report Segment
By Indication
By Type
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/europe-brachytherapy-market